Brief: Instil Bio Presents Subset Analysis Of Patients With Advanced Melanoma At 2021 Esmo Congress
16/09/2021 12:40
Sept 16 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO PRESENTS SUBSET ANALYSIS OF PATIENTS WITH
CHECKPOINT-REFRACTORY ADVANCED MELANOMA FROM COMPASSIONATE USE
STUDY AT 2021 ESMO CONGRESS
Source text for Eikon: ID:nGNX799jFk
Further company coverage: TIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses